Product Overview
BDP9066 | T14521 | TargetMol Chemicals
CAS: 2226507-04-4
Smiles: C1CC[C@@]2(CCCN(C2)c2cc[nH]c3ncc(-c4ccncn4)c23)NC1
Formula: C20H24N6
Pathway: Others
Target: Others
Receptor: N/A
Bioactivity: BDP9066 has therapeutic effect on skin cancer by reducing substrate phosphorylation. BDP9066 is a potent and selective myotonic dystrophy-related Cdc42-binding kinase MRCK inhibitor. With an IC50 of 64 nM for MRCKβ in SCC12 cells, Ki values of 0.0136 nM and 0.0233 nM for MRCKα/β in house determinations, respectively.
Molecular Weight: 348, 454